Clinical trial
Study on the Biomarkers to Predict the Response to Anti-vascular Endothelial Growth Factor Treatment for Choroidal Neovascularization
NCT06243406 is registered in ClinicalTrials.gov with Beijing Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study on the Biomarkers to Predict the Response to Anti-vascular Endothelial Growth Factor Treatment for Choroidal Neovascularization
- Lead sponsor
- Beijing Hospital
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- February 10, 2024
- Completion date
- October 31, 2024
- Enrollment
- 80 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.